Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02247388 · ClinicalTrials.gov registry record · NA
Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 840
- Enrollment target
NCT02247388: Completed NA study, sponsored by Yale University.
NCT02247388 is a NA study that has completed, run by Yale University. The registered enrollment target is 840 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02247388, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
Study Summary
To study the efficacy of AB-CASI against standard of care in a randomized controlled trial in the Emergency Department.
Primary Outcome
Self reported number of binge drinking episodes over the previous 28 days assessed using the 28 day timeline follow back at 12 months. This outcome was corrected 3/2020 to accurately reflect the time frame from the original protocol.
Interventions
- BEHAVIORAL Brief Negotiated Interview
- BEHAVIORAL Computerized Alcohol Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
What the finished NCT02247388 record still lists
NCT02247388 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief Negotiated Interview is the first listed.
NCT02247388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02247388 about?
NCT02247388 is a clinical study titled "Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI)". To study the efficacy of AB-CASI against standard of care in a randomized controlled trial in the Emergency Department.
What is the current status of trial NCT02247388?
This trial is currently completed. It is a NA study. The enrollment target is 840 participants. The study started on 2014-10. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT02247388?
The interventions under investigation include: Brief Negotiated Interview (BEHAVIORAL), Computerized Alcohol Screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT02247388?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02247388's enrollment target sits among peer trials
840 133rd of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia